Session Chair Profile

Ph.D., Sr. Director, Advanced Applications, NanoString Technologies

At NanoString Dr. Rhodes worked on all aspects of NanoString technologies as developed from a mid plex gene expression company, into a spatial biology company, culminating in the release of GeoMx DSP and CosMx SMI. A a post doc in Chicago working on genetics of metal transport in P. aeruginosa was followed returned to UK to work at United Kingdom Human Genome Mapping Project Resource Centre in charge of four teams: - Mouse resequencing, linkage Hotel, Academic Services and Custom services. Joined Applied Biosystems in 1999, worked on Genotyping, qPCR and Next Generation Sequencing. Joined NanoString in 2012 after seeing the potential of the nCounter technology to take the discoveries from NGS and apply them to translational research.

 Session Abstract – PMWC 2022 Silicon Valley

Track Chair:
Ira Mellman, Genentech

Human cells have been successfully used as treatment for blood cancers for decades but translating the promise to cell-based treatment for solid tumors has been slow. The advent of gene-editing techniques such as CRISPR, coupled with advances in our understanding of immunology and optimization of growing, manufacturing, transporting, storing, and handling specialized biological samples and materials is transforming the cell therapy field. We will hear in this session about some of the most promising work in the field, as well as the challenges in overcoming resistance

  • Recent Advances in Cell-based Therapy (PANEL)
    Session Chair: Sascha Rutz, Genentech
    - Susie Jun, ArsenalBio
    - Elliot Norry, Adaptimmune
    - Tina Albertson, Lyell
    - Hy Levitsky, Century Therapeutics
  • Cell-based Therapy Challenges (PANEL)
    Session Chair: Sharon Benzeno, Adaptive Biotechnologies
    - Arati Rao, PACT Pharma
    - Mark Kotter,
    - Hy Levitsky, Century Therapeutics
  • Synergistic Drug Combinations Targeting Tumor and Microenvironment
  • Next-generation Supply Chain For Cell & Gene Therapies (PANEL)
    Session Chair: Sharon Benzeno, Adaptive Biotechnologies
    - Ann Klein, Vineti
    - Tim Moore, Pact Pharma
    - Heidi Hunter, Cardinal Health
  • Biomarkers to Guide Immunotherapy
    Session Chair: Danny Wells, ImmunAI
    - Sanjeev Mariathasan, Genentech
    - Klaus Lindpaintner, InterVenn Bioscience
    - Lacey Padron, PICI
  • NaNots: A New Class of Immunotherapy
    - Lou Hawthorne, Nanotics
  • Advances in Multi-Omic Spatial Profiling
    Session Chair: Michael Rhodes, Nanostring
    - Chris Corless, OHSU
  • Engineered Therapeutics (PANEL)
    Session Chair: Paul Parren, Lava Therapeutics
    - Sonja Schrepfer, UCSF
    - Greg Lazar, Genentech